Metformin and colorectal cancer: a systematic review, meta-analysis and meta-regression
Sign Up to like & getrecommendations! Published in 2020 at "International Journal of Colorectal Disease"
DOI: 10.1007/s00384-020-03676-x
Abstract: Purpose Metformin may have a role in reducing the incidence of colorectal cancer (CRC) and improving survival outcome. This meta-analysis explored the effect of metformin use on colorectal adenoma and cancer incidence, and colorectal oncological… read more here.
Keywords: cancer; metformin users; meta; meta analysis ... See more keywords
Metformin use and cirrhotic decompensation in patients with type 2 diabetes and liver cirrhosis.
Sign Up to like & getrecommendations! Published in 2021 at "British journal of clinical pharmacology"
DOI: 10.1111/bcp.14970
Abstract: AIM To compare the risks of all-cause mortality, hepatic outcomes, major adverse cardiovascular events between metformin users and non-users for patients with diabetes and cirrhosis. METHODS From the Taiwan's National Health Insurance Research Database (NHIRD),… read more here.
Keywords: metformin users; metformin; metformin use; liver cirrhosis ... See more keywords
Effects of metformin use on total mortality in patients with type 2 diabetes and chronic obstructive pulmonary disease: A matched-subject design
Sign Up to like & getrecommendations! Published in 2018 at "PLoS ONE"
DOI: 10.1371/journal.pone.0204859
Abstract: Backgrounds Few studies have investigated the therapeutic effects of metformin in patients with type 2 diabetes mellitus (T2DM) and chronic obstructive pulmonary disease (COPD). We compared the risk of all-cause mortality between metformin users and… read more here.
Keywords: risk; cause mortality; metformin users; mortality ... See more keywords
Incidence and Survival Outcomes of Colorectal Cancer in Long-Term Metformin Users with Diabetes: A Population-Based Cohort Study Using a Common Data Model
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Personalized Medicine"
DOI: 10.3390/jpm12040584
Abstract: Background and aims: Previous studies have reported that metformin use in patients with diabetes mellitus may reduce the risk of colorectal cancer (CRC) incidence and prognosis; however, the evidence is not definite. This population-based cohort… read more here.
Keywords: cohort; crc incidence; incidence; metformin users ... See more keywords